Cargando…
ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme
BACKGROUND: Researches on immunotherapy of glioblastoma multiforme (GBM, WHO grade IV) have increased exponentially in recent years. As a targeted therapy, a series of biomarkers have been identified in local tumor tissue, while circulating marker which could be detected in the body fluids is still...
Autores principales: | Zhao, Zheng, Zhang, Ke-Nan, Chai, Rui-Chao, Wang, Kuan-Yu, Huang, Ruo-Yu, Li, Guan-Zhang, Wang, Yong-Zhi, Chen, Jing, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341252/ https://www.ncbi.nlm.nih.gov/pubmed/30728876 http://dx.doi.org/10.1155/2019/1802620 |
Ejemplares similares
-
The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts
por: Rypdal, Karoline B., et al.
Publicado: (2021) -
Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA
por: Yang, Qi, et al.
Publicado: (2018) -
Biomarkers for glioblastoma multiforme: status quo
por: Montano, Nicola, et al.
Publicado: (2016) -
Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018) -
Proteogenomic characterization and integrative analysis of glioblastoma multiforme
por: Song, Ying-Chun, et al.
Publicado: (2017)